Low temperature adaptor for evaporative light detection

Information

  • Patent Grant
  • 6362880
  • Patent Number
    6,362,880
  • Date Filed
    Wednesday, September 17, 1997
    27 years ago
  • Date Issued
    Tuesday, March 26, 2002
    22 years ago
Abstract
The present invention is directed to a system for converting between single flow and split flow evaporative light scattering detection devices for detecting samples in a mobile phase. Included in the system is a evaporative light scattering detection device, a low temperature adaptor, and a connection tube for providing a fluid connection between the evaporative light scattering detection device and the low temperature adaptor.
Description




FIELD OF THE INVENTION




Applicants' invention is directed to the field of evaporative light scattering detection and methods.




BACKGROUND OF THE INVENTION




Evaporative light scattering detection is a method of detecting samples that have been previously separated in various chromatography methods such as, for example, High Performance Liquid Chromatography (HPLC), Gel-Permeation Chromatography (GPC), High Performance Centrifugal Partition Chromatography (HPCPC), Field Flow Fractionation (FFF), and Supercritical Fluid Chromatography (SFC). Evaporative light scattering detection is preferably used when the sample components (e.g., components to be detected) have lower volatility than the mobile phase. A wide variety of sample types can be detected in evaporative light scattering detection. Such sample types include, for example, lipids, triglycerides, surfactants, polymers, underivatized fatty and amino acids, carbohydrates and pharmaceuticals.




Generally, evaporative light scattering detection involves four main steps: 1) nebulization of the chromatography effluent, (which consists of the mobile phase and the sample), into an aerosol of particles, 2) evaporation of the mobile phase, 3) light scattering by the sample particles, and 4) detection of the scattered light. There are two principal types of devices used in evaporative light scattering detection known in the art. In the first type (the “single flow” design), the nebulized chromatography effluent is immediately introduced into a heated drift tube where the mobile phase is evaporated. The sample particles are then flowed from the heated drift tube to an optical cell where light scattering and detection occurs. One such example of this type of device (the Alltech Model 500 ELSD) is sold by the assignee of this application, ALLTECH ASSOCIATES, INC. Details concerning the design and operating parameters for such a device are disclosed in the Operating Manual for the Alltech Model 500 ELSD, which is incorporated herein by reference.




In the second type of device, (the “split-flow” design), the nebulized chromatography effluent is first flowed through a nebulization chamber before entering the heated drift tube. In the nebulization chamber, the nebulized chromatography effluent is split, namely, the larger droplets are eliminated by condensation/impaction on the walls of the nebulization chamber. This condensate is drained to waste. Only the smaller nebulized droplets are subsequently flowed to the drift tube where the mobile phase (which is now free of the larger droplets) is more easily evaporated. Thereafter, the sample particles are flowed to the optical cell for light scattering and detection. Devices of this design type are available from, for example, SEDERE or EUROPSEP INSTRUMENTS.




The above-described design types have particular advantages depending on the mobile phase and the sample type. The single flow design is preferred for use in applications involving relatively non-volatile sample types and volatile organic mobile phases. Because all of the sample enters the optical cell in this design, response and sensitivity is maximized.




However, the split-flow design is preferably used with highly aqueous mobile phases and semi-volatile sample types. Highly aqueous mobile phases generally require higher evaporation temperatures. If the sample is volatile at these higher evaporation temperatures, sample loss is incurred during the evaporation step resulting in poorer sensitivity. By using the split-flow design, the evaporation temperature is reduced. This is accomplished by removing the larger mobile phase droplets in the nebulized chromatography effluent before the evaporation step. By removing the larger droplets, a smaller and more uniform particle size distribution is achieved in the mobile phase, which leads to lower evaporation temperatures. The lower evaporation temperatures, in turn, lead to less sample loss during the evaporation step. However, for non-volatile sample types and organic mobile phases, the split-flow design is generally less preferred because some of the non-volatile sample may be lost during the splitting of the chromatography effluent.




Another problem with devices of the split-flow design is that the split ratio of the sample (i.e., the amount that goes to waste versus the amount that is ultimately detected) is affected by, among other things, the laboratory temperature. In other words, fluctuations in laboratory temperatures lead to fluctuations in droplet size in the nebulized chromatography effluent. Thus, as ambient and/or laboratory temperatures fluctuate, the split ratio and corresponding reproducibility of sample detection may vary from run to run.




As is evident from the above-discussion, depending on the mobile phase and the sample type being detected, one evaporative light scattering detection design and method is advantageous over the other. However, laboratories often work with both aqueous and organic mobile phases and various sample types with different volatilities. Ideally, laboratories would have available both design types for evaporative light scattering detection. However, in order to have this benefit, the laboratory would need to purchase two separate devices, which can be expensive. It would be advantageous and constitute an improvement in the art if an evaporative light scattering detection device and system were developed which could be quickly and inexpensively converted between the single flow and split flow designs. Applicants have developed such a device and system. Moreover, with respect to the split-flow design, Applicants invention addresses the problem of the variation in split ratio caused by fluctuating laboratory temperatures.




SUMMARY OF THE INVENTION




In one respect, the present disclosure is directed to a system for evaporative light scattering detection which allows for quick and easy conversion between a single flow design and a split flow design, depending on the mobile phase and sample types to be detected. The system includes an evaporative light scattering detection device comprising a removably attached nebulizer in fluid communication with a heated drift tube, a light source, and a detector for detecting scattered light. The system also includes a low temperature adaptor comprising a nebulization chamber and a coil. The system further includes a connection tube for providing a fluid connection between the light scattering detection device and the low temperature adaptor for converting from a single flow to the split flow designs. One end of the connection tube is attached to the low temperature adaptor and the other end of the connection tube is removably attached to the evaporative light scattering detection device such that the connection tube provides fluid communication between the low temperature adaptor and the evaporative light scattering device. The low temperature adaptor is connected to the evaporative light scattering device by first removing the nebulizer from the detection device and attaching in its place the connection tube to provide fluid communication between the low temperature adaptor and the detection device. The low temperature adaptor further comprises a nebulizer. The nebulizer for the low temperature adaptor may be the nebulizer removed from the evaporative light scattering device or a second nebulizer.




The low temperature adapter in the above system further preferably comprises a sweep gas channel for introducing into the nebulization chamber sweep gas independently of the nebulizing gas. The sweep gas is for assisting in the evaporation of the mobile phase. Also, heat tape is preferably affixed to the nebulization chamber and the coil of the low temperature adaptor in the above system at pre-determined intervals for controlling the temperature of the nebulization chamber and coil.




In another respect, the disclosure is directed to a low temperature adaptor for a light scattering detection device which reduces the temperature required to evaporate the mobile phase. The low temperature adaptor is especially preferred for aqueous mobile phases and semi-volatile sample types. The low temperature adaptor comprises a nebulization chamber, a coil and a connection tube for removably attaching the low temperature adaptor to the evaporative light scattering detection device such that the connection tube provides a fluid connection between the low temperature adaptor and the evaporative light scattering detection device. Heat tape is preferably affixed to the nebulization chamber and the coil at pre-determined intervals for controlling the temperature of the nebulization chamber and coil. The low temperature adaptor preferably further includes a sweep gas channel for introducing sweep gas into the nebulization chamber independently of nebulizing gas. Finally, the low temperature adapter further includes a nebulizer. The nebulizer may be the nebulizer removed from the evaporative light scattering detection device prior to connecting the low temperature adapter or a second nebulizer.




In another aspect, the disclosure concerns a method of evaporative light scattering detection which is substantially resistant to fluctuations in ambient temperature conditions. By substantially resistant to fluctuations in ambient temperature conditions, it is meant that the detection device of this invention provides consistent detection when laboratory temperatures fluctuate of from about 15° C. to about 40° C. The method comprises flowing nebulized chromatography effluent comprising mobile phase and sample to be detected through a nebulization chamber, wherein the temperature of the nebulization chamber is controlled by a heat source; reducing the particle size distribution of the nebulized chromatography effluent in the nebulization chamber; evaporating the mobile phase; and detecting the sample by evaporative light scattering detection. Preferably, the temperature in the nebulization is controlled by heat tape affixed to the nebulization chamber at predetermined intervals.











DESCRIPTION OF THE DRAWINGS





FIG. 1

is a schematic diagram illustrating the principles of operation of an evaporative light scattering detection device.





FIG. 1



a


is an isometric view of the configuration for an evaporative light scattering detection device.





FIG. 2

is a cross-section view along line A—A of

FIG. 1

showing the drift tube assembly.





FIG. 3

is a cross-section along lines A—A and B—B of

FIG. 1

of the nebulizer and nebulizer adaptor.





FIG. 3



a


is a top view of the nebulizer and nebulizer adaptor shown in FIG.


3


.





FIG. 3



b


is a side view of the nebulizer body portion of the nebulizer shown in FIG.


3


.





FIG. 4

is a cross-section view along line A—A of

FIG. 1

showing the manner of connecting the nebulizer to the drift tube assembly.





FIG. 5

is a perspective isometric view of the configuration for a low temperature adaptor.





FIG. 6

is a top isometric view of the configuration for a low temperature adaptor.





FIG. 7

is a perspective view of the coil and nebulization chamber of the low temperature adaptor.





FIG. 8



a


is a partial cross-section view along line A—A of

FIG. 6

showing the attachment of the nebulizer union to the nebulization chamber of the low temperature adaptor.





FIG. 8



b


is a cross-section view along lines A—A and C—C of FIG.


6


.





FIG. 8



c


is a top plan view of

FIG. 8



a.







FIG. 9

is a diagram depicting sample flow through the low temperature adaptor and the evaporative light scattering device.





FIG. 10

is a cross-section view along line D—D of

FIG. 9

showing the connection between the low temperature adaptor, connection tube and evaporative light scattering device.





FIGS. 11-21

are chromatograms demonstrating the use of the evaporative light scattering detection device and low temperature adaptor disclosed herein.











DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS





FIGS. 1-4

illustrate an evaporative light scattering detection device of the single flow design.

FIG. 1

provides an overview of the principal of operation of an evaporative light scattering detection device


10


. The scattering device


10


has a connector


12


. The connector


12


provides a fluid connection between the chromatography column (not shown) and the evaporative light scattering device


10


. The connector


12


is preferably made from stainless steel and is threadingly engaged to nebulizer bracket


16


. Chromatography effluent is flowed into the evaporative light scattering device


10


through channel


13


in connector


12


. Nebulizer bracket


16


removably attaches nebulizer


14


(which consists of pieces


101


,


102


and


103


discussed below) to drift tube assembly


18


. The nebulizer


14


contains a nebulizer needle (not shown). The drift tube assembly


18


surrounds a central heated drift tube channel


11


. Finally, a laser light source


20


, a photodetector


22


and amplifier


24


are provided.




In operation, and with reference to

FIG. 1

, the chromatography effluent is flowed through connector


12


to nebulizer


14


. The chromatography effluent is directed through the nebulizer needle (not shown). Upon exiting the nebulizer needle, the chromatography effluent is impacted by nebulizing gas to form an aerosol of droplets, preferably of generally uniform size. The nebulizing gas may include any gas that is inert to the sample such as helium, carbon dioxide, air or nitrogen, and is preferably nitrogen.




The nebulized chromatography effluent is then flowed through channel


11


in the drift tube assembly


18


. In channel


11


, the mobile phase is evaporated leaving behind the non-volatile sample particles. The non-volatile sample particles are flowed through channel


11


to the light scattering zone


19


for detection. A light source


20


emits light, which the sample particles scatter. The scattered light is then detected at the photodetector


22


. The photodetector


22


then produces a signal which is sent to an amplifier


24


though analog outputs in the photodetector.




The light source


20


is preferably a Class IIIA laser product with a 650 nm laser diode, 5 mW maximum power, collimating optics, and polarized. A preferred laser light source is available from COHERENT, as part no. VLM3-5L. The photodetector


22


is preferably made from a silicon photodiode. A preferred photodetector


22


is available from HAMAMATSU, as part no. S2386-8K. The photodetector


22


is preferably located at a 90 degree angle from the light source


20


. A light trap


31


is also preferably located at an 180 degree angle from the light source


20


to collect any light not scattered by the sample particles in the aerosol stream. After detection in the detection zone, the sample particles are flowed through an exhaust line (now shown) to waste. Preferably the exhaust is flowed to a fume hood or other ventilation device located close to the detector to remove the detector exhaust from the laboratory.




A configuration and preferred flow paths for the sample and the nebulizing gas of an evaporative light scattering device


10


is illustrated by

FIG. 1



a


. Preferably included in the evaporative light scattering device


10


is liquid pressure sensor


33


, liquid back pressure relief valve


34


, gas shut off valve


35


, mass flow sensor


36


and mass flow control


36




a


, gas pressure sensor


37


, temperature control


38




a


, power input


39


, logic board


38


(which includes a microprocessor) and front control panel


38




c


. The logic board


38


is in electrical communication (not shown) with front panel display


38




c.






The liquid back pressure relief valve


34


is in fluid communication with the nebulizer


14


via a stainless steel flow path (not shown). If the nebulizer needle becomes blocked or chromatography effluent back pressure otherwise exceeds a pre-determined level, the back pressure relief valve


34


diverts the flow of chromatography effluent from nebulizer


14


to waste. A preferred back pressure relief valve is a diaphragm back pressure regulator available from the assignee of this application ALLTECH ASSOCIATES, INC. The liquid pressure sensor


33


is also in fluid communication with the nebulizer


14


via a stainless steel flow path (not shown). The liquid pressure sensor monitors the chromatography effluent back pressure in the nebulizer


14


. The liquid pressure sensor


33


is also in electrical communication (not shown) with logic board


38


and communicates pressure readings to logic board


38


for display on front panel


38


c. A preferred liquid pressure sensor is available from KELLER PSI, as part no. PR-6-10. The sample in the chromatography effluent is flowed from nebulizer


14


through drift tube assembly


18


to detection zone


19


for sample detection.




The nebulizing gas is flowed from gas inlet


30




a


to gas filter


30


where impurities are removed from the nebulizing gas. A preferred gas filter has a 1 micron pore size and is available from WEBSTER ASSOC., as part no. FILNO5012YE. The nebulizing gas is then flowed from gas filter


30


through, respectively, gas pressure sensor


37


, gas shut-off valve


35


, mass flow controller


36




a


, mass flow sensor


36


to nebulizer


14


. Each of the foregoing devices are in gas communication via TEFLON tubing. The gas pressure sensor


37


monitors the nebulizing gas and is in electrical communication with logic board


38


. The gas pressure sensor


37


triggers an alarm if the nebulizing gas pressure falls below or exceeds pre-determined levels. A preferred gas pressure sensor is available from IC SENSORS, as part no. 1201A-100G-3L. The gas shut-off valve


35


is in electrical communication with logic board


38


and may be triggered to stop the flow of nebulizing gas as, for example, between detection runs. The mass flow controller


36




a


is manually operated for setting the flow rate of the nebulizing gas. A preferred mass flow controller allows for nebulizing gas flowrates of from 0-5 Standard Liters Per Minute (SLPM) and is available from CONDYNE, as part no. 100-6(14)4. The mass flow sensor


36


measures the flow rate of the nebulizing gas and is in electrical communication with logic board


38


, which in turn displays the nebulizing gas flowrate on front control panel


38




c


. A preferred mass flow sensor is available from INTEGRATED ELECTRONICS, as part no. AWM43600V.




The logic board


38


further processes the analog signal from the photodetector


22


and contains a microprocessor for displaying readings from the mass flow sensor on an LCD (not shown) on the front panel


38




c


. Preferably, each of the foregoing components are contained within the same housing


10




a.






In operation, the nitrogen nebulizing gas is preferably regulated from 45-80 psig with 99.9% purity or better. A stable gas flowrate and pressure are necessary for reproducible results. The gas is preferably free of contaminants, such as oil, water, particulate or any other non-volatile substances. The droplet size in the nebulized chromatography effluent may be regulated by varying the flow rate of either the chromatography effluent and/or the nebulizing gas. The lower the flow rate of the chromatography effluent, the less gas and heat necessary for nebulization and subsequent evaporation.





FIGS. 2

,


3


and


4


and illustrate the construction of the nebulizer


14


and the drift tube assembly


18


in more detail. The drift tube assembly


18


comprises four phenolic cover plates


40


surrounding insulation


42


. The insulation


42


is preferably ½ inch polyimide available from McMASTER CARR, as part no. 446K121. The insulation


42


, in turn, surrounds surface heaters


44


. The surface heaters are thermoelectric heating elements preferably of silicon pad style available from WATLOW, as part no. F030050C7. The surface heaters are preferably mounted by an appropriate adhesive on heating tube


46


. Heating tube


46


is preferably made from aluminum or other appropriate thermally conductive material. A drift tube


47


is telescopically positioned by a slip fit within heating tube


46


. The drift tube


47


, which surrounds channel


11


, is preferably constructed from stainless steel. A thermal fuse


43


(shown in phantom) is preferably provided for turning the heat off if temperature exceeds a pre-determined limit. The fuse is in electrical communication with the power source for the silicon heaters


44


. Also preferably included is temperature sensor


54


for monitoring the temperature in the drift tube assembly


18


. The sensor is in electrical connection with logic board.




With reference to

FIGS. 3

,


3




a


and


3




b


, the nebulizer


14


comprises a nebulizer tee nozzle


101


, a nebulizer body


102


, nebulizer adaptor


103


, and tip piece


104


. The nebulizer body


102


is attached to tee nozzle


101


by bolts


105


. Preferably, six bolts


105


are provided (see

FIG. 3



a


). The adaptor


103


is removably secured to the drift tube assembly


18


(see FIG.


4


). The tee nozzle


101


, nebulizer body


102


and nebulizer adaptor


103


are preferably made from stainless steel. O-rings


109


,


109




a


and


109




b


are provided to give a liquid and air tight seal between the tee nozzle


101


, nebulizer body


102


, and nebulizer adaptor


103


. O-rings


109


,


109




a


and


109




b


are VITON O-rings available from DUPONT. Bottom seal


104




c


provides a gas and liquid seal between body


102


and adapter


103


. Bottom seal


104




c


is preferably a teflon/SS seal available from VERI-SEAL as part no. W10-MH-P-012-X-1. The tip piece


104


is removably secured to nebulizer body


102


by threads


104




a


and complementary threads


104




b


. Openings


104




d


are provided in tip


104


for receiving a two-pronged adjustment tool which assists in adjusting tip


104


relative to nebulizer body


102


.




A chromatography effluent port


108


is provided for introducing and flowing the chromatography effluent into the nebulizer


14


and to nebulizer needle


112


. Chromatography effluent port is in fluid communication with connector


12


(see

FIG. 2

) by a standard nut and ferrule connection. A back pressure channel


106


is also provided which is in fluid communication with liquid back pressure relief valve


34


(see

FIG. 1



a


). A liquid pressure sensor channel


106




a


(see

FIG. 3



a


) is also provided which is in fluid communication with liquid pressure sensor


33


(see

FIG. 1



a


). If chromatography effluent back pressure in the nozzle exceeds a pre-determined limit, the liquid back pressure relief valve diverts chromatography effluent flow away from the nebulizer through liquid back pressure relief valve


34


to waste. Channels


106


and


106




a


are in fluid connection with, liquid back pressure relief valve and liquid pressure sensor, respectively, by stainless steel tubing connected to channels


106


and


106




a


by standard nut and ferrule connections available from ALLTECH as part nos. 206085 (nut) 286075 (ferrule).




The nebulizer needle


112


comprises two concentrically positioned needles which have been silver soldered to each other. Preferably, there is no void between the concentrically positioned needles. The nebulizer needle


112


has a longitudinal channel through which the chromatography effluent is flowed. The nebulizer needle


112


is preferably constructed from stainless steel. The nebulizer needle


112


is maintained in fluid connection with chromatography effluent port


108


by nut


116


. Nut


116


has a longitudinal bore in which nebulizer needle


112


sits. Preferably, the internal diameter of the nebulizer needle is between about 0.007 to about 0.012 of an inch.




The nebulizer body further comprises set screws


112




a


for centering the nebulizer needle


112


. It is important to center the nebulizer needle so that the chromatography effluent exiting the needle is substantially in the concentric center of the nebulizing gas. The pressurized nebulizing gas is introduced into the nebulizer through nebulizing gas port


118


in nebulizer adaptor


103


. The nebulizer gas flows into channel


105




a


formed between nebulizer adaptor


103


and shoulders


102




a


and


102




b


of nebulizer body


102


. A small opening


105




b


is formed in the nebulizer body


102


generally in the plane of the set screws


112




a


(see

FIG. 3



b


). The pressurized nebulizing gas flowing through opening


105




b


is forced into nebulizing gas chamber


130


. Because seal


109




a


provides a gas tight seal, the pressurized nebulizing gas is forced inside tip


104


into nebulizing zone


132


. The nebulizing gas strikes the chromatography effluent exiting the nebulizer needle


112


in the nebulizing zone


132


. The nebulizing gas breaks-up the chromatography effluent to form an aerosol of droplets. The chromatography effluent aerosol is then flowed to the drift tube assembly


18


for the evaporation step as discussed above. In addition to set screws


112


for centering the nebulizer needle, nebulization (e.g. droplet particle size) may also be varied by adjusting tip


104


.





FIGS. 3 and 4

illustrates the fluid connection between the nebulizer


14


and drift tube assembly


18


. The nebulizer


14


is removably secured to the drift tube assembly


18


by operation of nebulizer bracket


16


, screws


16




a


, nebulizer adaptor


103


and drift tube cap


118




a


. The nebulizer adaptor


103


has an L-shaped channel


119


for receiving the drift tube assembly


18


. In particular, a terminal end


18




b


of the tube


47


of the drift tube assembly


18


is positioned in void


119




a


of channel


119


. A clip


109




e


is attached to the terminal end of tube


47


to provide a shoulder for resting upon the drift tube cap


118




a


. An O-ring


109




d


provides a liquid and gas tight seal at the junction of the terminal end of tube


47


with nebulizer adaptor


103


. The drift tube assembly


18


further has a drift tube cap


18




a


which fits into channel


119


of the nebulizer adaptor


103


. Screws


119




e


are provided to removably secure the drift tube cap


18




a


to the nebulizer adaptor


103


. Finally, nebulizer bracket


16


has channels


16




b


for receiving screws


16




a


. Shoulder


16




c


of the nebulizer bracket


16


abuts against shoulder


14




a


of nebulizer


14


. Shoulder


14




b


of nebulizer


14


abuts against surface


103




a


of nebulizer adaptor


103


. Thus, when screws


16




a


are inserted through channel


16




b


and into channels


103




b


formed in nebulizer adaptor


103


(not shown in FIG.


3


), the nebulizer is removably secured in fluid communication with the drift tube assembly


18


.




As those skilled in the art will recognize, nonvolatile impurities in the mobile phase or nebulizing gas will be detected thereby producing baseline “noise.” By using the highest quality gas, solvents and volatile buffers which are preferably filtered, the baseline noise will be reduced. Baseline noise will also result from the mobile phase not being completely evaporated. Also, the sample may be volatilized if the drift tube temperature is too high or the sample is too volatile. The temperature in the heated drift tube


18


and the flowrate for the nebulizing gas are dictated by the volatility and flow rate of the mobile phase. At a mobile phase flowrate of 1 mL/min., the following drift tube temperatures (in ° C.) and nebulizing gas flowrates (in Standard Liters Per Minute (SLPM)) are recommended: acetone (45 C, 1.50); acetonitrile (70 C, 1.70); heptane (50 C, 1.60); hexane (60 C, 1.60); isopropyl alcohol (80 C, 2.20); methanol (70 C, 1.65); methylene chloride (75 C, 2.00); water (115 C, 3.20); methanol:water (90:10) (70 C, 2.00); and acetonitrile:water (75:25) (90 C, 2.00).




When calculating the starting temperature and nebulizing gas flowrate for mixed mobile phases, the above values in the same ratio as the mobile phase solvents are to each other should be used. Thus, if running a binary mobile phase of 60% methanol and 40% water, the temperature would be (0.6)(70)+(0.4)(115)=88 C. The nebulizing gas flowrate would be (0.6)(1.65)+(0.4)(3.20)=2.27 SLPM. The above recommended temperature and nebulizing gas flowrates should be adjusted if the mobile phase flowrates are changed from 1 mL/min. Lower mobile phase flowrates generally require lower nebulizing gas flowrates and temperature. On the other hand, higher mobile phase flowrates may require higher nebulizing gas flowrates and temperature.




Finally, with respect to solvents not discussed above, suitable starting drift tube temperatures and nebulizing gas flowrates may be estimated as follows. Obtain from an appropriate reference the solvent's boiling point and vapor pressure. Use the temperature and gas flowrate of the solvent listed above that most closely matches the boiling point and vapor pressure of the solvent of interest.




Of course, some experimentation may be necessary to obtain the optimum gas flowrate, mobile phase flowrate and temperature for any particular analysis. The nebulizing gas flow rate determines the mobile phase droplet size. Higher flowrates produce smaller droplet sizes which enhance vaporation. On the other hand, smaller droplets produce smaller sample particles which scatter less light and produce smaller signals for detection. Generally, the optimal nebulizing gas flowrate is the lowest flowrate that will produce the largest peaks with an acceptable, low noise baseline. This can be determined by finding the signal to noise ratio of various flowrates. By plotting the signal to noise ratio vs. peak area and/or the gas flowrate vs. peak area, the optimal gas flowrate may be determined.




With respect to the flowrate of the mobile phase, higher flowrates require higher gas flowrates and higher temperatures. It is therefore preferable to use the lowest mobile phase flowrate possible. The temperature selection depends on mobile phase volatility, and flowrate, and nebulizing gas flowrate. Aqueous solvents require higher temperatures than organic solvents. Lower nebulizing gas flowrates produce larger droplets and, therefore, require higher temperatures for evaporation. Preferably, the lowest temperature that will produce an acceptable, low noise baseline should be used. When working with temperature sensitive samples that are volatile at the temperature necessary to evaporate the mobile phase, the drift tube temperature may be decreased by increasing the nebulizing gas flowrate. However, because smaller droplets are produced, the increased gas flowrate will decrease detection sensitivity of the sample.




When it is desired to convert from the single flow design as previously described to the split-flow design, when, for example, aqueous mobile phases and semi-volatile samples are present, this conversion may be quickly and easily accomplished by using the low temperature adaptor of the present invention. To accomplish the conversion, the nebulizer bracket


16


and nebulizer


14


are removed from the nebulizer adaptor


103


by removing screws


16




a


and manually removing these pieces (see FIG.


4


). The low temperature adaptor is inserted in place of the nebulizer


14


as described below with reference to FIG.


10


. However, before discussing the manner in which the low temperature adapter is connected to the evaporative light scattering detection device, an overview of the low temperature adapter construction is provided.




Isometric views of the low temperature adaptor according to one embodiment of the invention are illustrated in

FIGS. 5-6

. The low temperature adaptor


200


has a nebulizer


14


. The nebulizer


14


is the same as the nebulizer previously described. The nebulizer


14


may either be the nebulizer


14


removed from the evaporative light scattering device


10


before attaching the low temperature adaptor, or it may be a second nebulizer. The nebulizer


14


is connected to a nebulization chamber


208


by nebulizer union


206


. Details concerning the manner of attachment of the nebulizer


14


to the nebulizer union


206


are discussed below with reference to

FIGS. 8



a


and


8




b


. The nebulizer union


206


is preferably made from stainless steel and is friction fit to the nebulization chamber


208


by O-ring


246


. The nebulization chamber


208


has a sink trap drain


212


. A tapered connector


216


attaches the nebulization chamber


208


to coil


218


. The connector


216


is preferably made from stainless steel and is welded to the chamber


208


and coil


218


. The chamber


208


and coil


218


are also preferably made from stainless steel. The coil


218


is preferably ½ inch or 1 inch in diameter. The foregoing pieces are preferably contained in housing


222


.




A gas filter in-line


226


is preferably provided for supplying the sweep gas to the nebulizer union member


206


as described below. A back pressure line


227


is also preferably provided to flow chromatography effluent away from the nebulizer


14


to waste when chromatography effluent exceeds a pre-determined pressure limit. The coil


218


exits housing


222


to flow the nebulized chromatography effluent to the evaporative light scattering detection device via connection tube


260


described herein. Finally, the housing


222


also preferably includes power module


232


, temperature controller


233


, sweep gas regulator


209


, back pressure regulator


235


, sold state relay


236


, and mass flow controller


248


.




Sweep gas regulator


209


regulates the flowrate of the sweep gas introduced to the nebulizer


14


from a sweep gas source (not shown). Preferably, the sweep gas is selected from the same gas as the nebulizing gas. Most preferably, the sweep gas is nitrogen. Suitable tubing (not shown) provides a gas connection between the sweep gas regulator


209


and the nebulizer union


206


. Back pressure regulator


235


is in fluid connection with nebulizer


14


by stainless steel. If the back pressure exceeds a pre-determined level, the back pressure regulator diverts chromatography effluent flow from nebulizer


14


through back pressure regulator


235


to back pressure waste line


235




a


(not shown in its entirety). Back pressure waste line


235




a


exits the low temperature adapter housing


222


and flows the chromatography effluent to waste. A preferred back pressure regulator is a diaphragm back pressure regulator available from the assignee of this application, ALLTECH ASSOCIATES, INC. The solid state relay


236


is in electrical connection with the heat tape


228


affixed to nebulization chamber


208


and coil


218


and temperature controller


233


. The solid state relay turns the heat tape “on” and “off” in response to the temperature controller


233


. A preferred temperature controller is a PID action, TC input available from WATLOW, as part no. 965A3CA000BR. A preferred solid state relay is available from NEWARK, as part no. 27F329. The mass flow controller


248


controls the flow of nebulizing gas to the nebulizer


14


. The mass flow controller


248


is in gas communication with the nebulizer


14


and the nebulizing gas source (not shown) by suitable tubing, as for example TEFLON tubing. A preferred mass flow controller is as previously described with respect to the evaporative light scattering device


10


.




The low temperature adapter preferably uses one gas source for both the nebulizing gas and the sweep gas. Preferably, the gas (which is preferably nitrogen) enters the low temperature adapter housing


222


at “gas in” line


239


. After entering the low temperature adapter, the gas is split into two gas streams. The first stream, the sweep gas is flowed to a sweep gas filter (not shown) for removing impurities from the sweep gas. The sweep gas is then flowed from the filter to the sweep gas regulator


209


and nebulizer


14


, respectively. The second stream, the nebulizing gas, is flowed out of the low temperature adapter housing


222


via “ELSD out” line


239




a


. The nebulizing gas is flowed into the evaporative light scattering device


10


where it is filtered by nebulizing gas filter


30


in the scattering device


10


. After filtering to remove impurities, the nebulizing gas is flowed through mass flow sensor


36


in the scattering device


10


and back to the low temperature adapter through “ELSD in” line


239




b


to mass flow controller


248


and nebulization chamber


208


, respectively.




With reference to

FIG. 7

, heat tape


228


is preferably wrapped around the nebulization chamber


208


and the coil


218


at predetermined intervals. By varying the amount of heat tape on the nebulization chamber


208


and the coil


218


, a heat application gradient may be established. Preferably, heat is applied at a higher rate at the nebulization chamber


208


than at the coil


218


. The majority of evaporation takes place in the nebulization chamber, and the surface area per unit length in the nebulization chamber


208


is greater than in the coil


218


. If there is not enough heat in the nebulization chamber, a greater percentage of the mobile phase will pass through the chamber and ultimately to the optical cell for detection. This will result in an unstable baseline and hinder detection of the sample. On the other hand, if there is too much heat applied at the coil


218


, there is a risk of evaporating sample which will reduce the amount of sample detected. By asymmetrically applying the heat tape at the nebulization chamber


208


, and the coil


218


, more heat may be delivered to the nebulization chamber


208


than to the coil


218


using the same heat source. When ½ inch coil is used, it is preferred to leave ½ to ¾ inch spacing between the heat tape. When 1 inch coil is used, it is preferred to leave ⅛ inch spacing between the heat tape. Most preferably, the amount of heat tape per surface area is greater in the nebulization chamber


208


than in coil


218


. Most preferably, the ratio of applied heat per unit surface area in the nebulization chamber


208


to the coil


218


is about 1:1 to about 3:1 and most preferably about 1.7:1. The heat tape


228


is preferably cut from ½ inch width H-series heat tape. Preferred heat tape is available from CLAYBORN, under part no. J-16-4. The heat tape is in electrical connection with power module


232


in the low temperature adaptor housing


222


(see FIG.


5


).





FIGS. 8



a


and


8




b


further illustrates the connection between the nebulizer


14


and the nebulizer union


206


of the low temperature adaptor. The nebulizer consists of tee nozzle


101


, nebulizer body


102


and tip


104


and is as previously described with reference to

FIGS. 3

,


3




a


, and


3




b


. Chromatography effluent is delivered to tee nozzle


101


by the same means previously described with respect to connector


12


and chromatography effluent line


12




a


. The union


206


has a sweep gas port


240


and sweep gas channel


241


, which are in gas communication with nebulization chamber


208


. Port


240


and channel


241


are for introducing sweep gas to the nebulization chamber


208


. Port


240


is in gas communication with sweep gas regulator


209


(see FIGS.


5


and


6


). The sweep gas is preferably introduced into the same plane as the tip of the nebulizer needle and parallel to the nebulizing gas. The purpose of the sweep gas is to assist in evaporating the mobile phase and to provide a way of controlling the evaporation rate without affecting nebulization and particle size distribution in the mobile phase. The nebulizer union


206


further includes nebulizing gas port


242


which introduces nebulizing gas to the nebulizer as previously described with respect to

FIGS. 3

,


3




a


, and


3




b


. Nebulizing gas flow rate is controlled by any suitable gas valve or valving arrangement. Preferably, the nebulizing gas is delivered from the same nebulizing gas source as used by the evaporative light scattering detection device. Seal


246


provides a gas tight seal between the inside wall


251


of nebulization chamber


208


and nebulizer union


206


. This seal is preferably EPDM rubber seal available from McMASTER CARR, Chicago, Ill., as part no. 9557K19. Nebulizer


14


is removably attached to union


206


by screw


505


.





FIG. 9

illustrates the flow path and method of operation when the low temperature adaptor is used in conjunction with the evaporative light scattering device. The chromatography effluent is flowed through a nebulizer


14


and nebulizer union


206


. The nebulized chromatography effluent is flowed to nebulization chamber


208


where the larger droplets of the mobile phase collide with the inside walls of the chamber


208


and are flowed to waste via sink trap


212


. By removing the larger particles in the chromatography effluent, a smaller droplet size distribution is created and the temperature required to evaporate the remaining droplets of the mobile phase is reduced. Hence the name “low temperature adaptor.” To avoid widely fluctuating temperatures that may adversely affect reproducibility, the temperature of the nebulization chamber


208


is precisely controlled with the heat tape


228


. Evaporation of the mobile phase begins in the nebulization chamber


208


. The “split” nebulized chromatography effluent is then flowed through heated coil


218


where evaporation of the mobile phase continues. Because of the smaller particle size distribution in the mobile phase, the evaporation temperatures used in the coil


218


are lower than if the chromatography effluent was not first split in the nebulization chamber


208


. By operating at a lower evaporation temperatures, the low temperature adaptor improves the sensitivity of the system to semi-volatile samples. The sample, which has not been evaporated, is then flowed through connection tube


260


and drift tube assembly


18


, respectively, to detection zone


19


.





FIG. 10

illustrates the interface between the low temperature adaptor and the evaporative light scattering device. The coil


218


is secured to the bottom of housing


222


for the low temperature adaptor by coil connection plate


250


. The connection plate


250


is welded to the coil


218


and is removably secured to the housing


222


by hex head nuts


251


and socket head cap screws


253


. A channel


256


extends along a vertical axis through connection plate


250


. A shoulder


257


is positioned in channel


256


. A lower end of coil


218


abuts against one side


257




a


of shoulder


257


. A connection tube


260


is inserted into channel


256


until it abuts against the opposite side


257




b


of shoulder


257


. An O-ring


261


is provided to form a gas and liquid tight seal between connection tube


260


and the inside wall of channel


256


of connection plate


250


. O-ring


261


is preferably EPDM rubber such as McMASTER CARR part no. 9557K2-018.




The connection tube


260


(which is preferably made from stainless steel) is in fluid communication with tube


47


of drift tube assembly


18


of the evaporative light scattering device


10


. In particular, the housing for the evaporative light scattering device


10


has a recess


10




a


. The recess


10




a


is exposed by removing a removable cover cap (not shown) from the housing of evaporative light scattering device


10


. The removable cover cap is configured to cover the recess


10




a


when the system is in the single flow configuration and, therefore, the low temperature adaptor is not on-line. Sitting in recess


10




a


is the drift tube assembly


18


. Attached to the drift tube assembly


18


is drift tube cap


118




a


. The nebulizer adaptor


103


is removably secured to the drift tube cap


118




a


by screws


119




e


as previously described. Nebulizer adaptor


103


has screw channels


103




b


for receiving screws


16




a


. Connection tube plate


266


is, therefore, removably secured to nebulizer adaptor


103


by screws


16




a


. Connection tube plate


266


has a bore for receiving connection tube


260


. Connection tube seal


280


provides a gas and liquid tight seal between the connection tube


260


and connection tube plate


266


. Connection plate seal


282


provides a gas and liquid tight seal between connection tube plate


266


and nebulizer adaptor


103


. Seal


280


is the same type as seal


260


and seal


282


is the same type as seal


246


. As can be ascertained from comparing

FIGS. 4 and 10

, the low temperature adaptor may be quickly and easily attached to the evaporative light scattering device


10


by removing the nebulizer bracket


16


and nebulizer


14


, and then inserting connection tube


260


through nebulizer adaptor


103


, applying connection tube and connection plate seals


280


and


282


, respectively, and securing screws


16




a


. By following these simple steps and re-routing nebulizing gas flow and the chromatography effluent flow, an evaporative light scattering detection device


10


may be quickly and easily converted between the single flow and split flow designs.




The low temperature adaptor is intended to operate at low temperatures and low nebulizing gas flow rates. The low temperature adaptor will be preferably operated in a temperature range of ambient to 100 C in 1C increments. The nebulizing gas is preferably nitrogen with a pressure range of about 45 to about 80 psig and a flow rate of (0-5 SLPM). The mobile phase flowrate is preferably about 0.1 to about 5.0 mL/min. The temperature controller is preferably a microprocessor based PID temperature controller. The mobile phase flow path is preferably made from stainless steel. The gas flowpath is preferably made from TEFLON tubing. In general, an operating temperature of about 40 C and a nebulizing gas flow rate of 1.75 SLPM is sufficient for most applications. However, to obtain maximum detector response for each application, some experimentation may be necessary to determine optimum temperature and nebulizing gas flowrate.




Temperature selection depends mainly on the volatility of the mobile phase used, but is also affected by the mobile phase flowrate. Aqueous solvents require slightly higher temperatures than organic solvents. A temperature of about 40 C is sufficient to evaporate mobile phases consisting of 100% water at flowrates up to 2.0 mL/min. and, therefore, is a good starting point. Mobile phases containing a large portion of organics may require temperatures as low as ambient (25 C). The low temperature adaptor is preferably not used with such mobile phases unless semi-volatile samples are involved. Most preferably, the lowest temperature that produces an acceptable, low noise baseline should be used for most applications. It should also be noted that the low temperature adaptor and the evaporative light scattering device should be operated at the same temperature.




The nebulizing flowrate selection will also depend on mobile phase volatility and mobile phase flowrate. Preferably, nebulizing gas flowrates will be under 2.0 SLPM, unless extremely high mobile phase flowrates are used. For low mobile phase flowrates or highly organic mobile phases, nebulizing gas flowrates may be as low as 1.0 SLPM. Most preferably, the lowest gas flowrate that produces an acceptable, low noise baseline should be used.




In general, when using non-volatile samples and organic mobile phases, the single flow evaporative light scattering device may be used. However, when switching to semi-volatile sample types, aqueous mobile phases and/or higher mobile phase flowrates, the evaporative light scattering device of the present invention may be quickly and easily converted to a split flow design as described herein.




Following are examples demonstrating how to use the invention disclosed herein. With respect to the examples using the low temperature adapter, unless otherwise stated, nitrogen sweep gas was used at 2 SLPM. In the examples, heat tape was affixed to the coil and nebulization chamber such that the amount of heat tape on the nebulization chamber per unit service area was 1.7 times greater than that affixed to the coil.




EXAMPLES




Example 1





FIGS. 11 and 12

demonstrate the improved baseline stability obtained when using the low temperature adaptor (LTA) in combination with the evaporative light scattering detection (ELSD) device with a highly aqueous mobile phase. When highly aqueous mobile phases are used for the separation, higher drift tube temperatures are needed. The LTA permits effective detection of lower evaporation temperatures.

FIG. 11

is a chromatogram of the ELSD alone.

FIG. 12

is a chromatogram of the LTA/ELSD combination. The separation column was an Econosphere C18, 3 μm, 30×4.6 mm; the mobile phase was methanol: water: acetic acid (38:62:1); the flowrate 1.5 mL/min; sample size was 0.2 mg/mL caffeine, 0.8 mg/mL aspirin. With respect to

FIG. 11

, drift tube temp. 95° C., 20 μL loop, nebulizing nitrogen flow rate 3.70 SLPM. With respect to

FIG. 12

, drift tube temp. 50° C.; nitrogen flow 2.5 SLPM; nebulizer chamber temp. 38° C.; coil temp. 60° C.; nitrogen sweep gas flow 3 SLPM.




Example 2




The ELSD alone is preferred for non-volatile samples or organic mobile phases. The ELSD alone is preferred when analyzing non-volatile compounds or when using organic mobile phases.

FIGS. 13 and 14

demonstrate this. Organic mobile phases evaporate easily, reducing operating temperatures so that sample integrity is preserved. When using the ELSD alone, all of the sample enters the optical cell, maximizing response. With respect to

FIGS. 13 and 14

, separation was by HPLC. Column was Adsorbosphere C18, 5 μm, 250×4.6 mm. Mobile phase was methanol: acetonitrile (97:3); the sample size was 20 μL injection loop, mobile phase flowrate 1.0 mL/min. With respect to

FIG. 13

, the drift tube temp. was 70° C. and nebulizing nitrogen flow was 2.00 SLPM.




Example 3




The ELS/LTA combination is preferred with semi-volatile samples. The LTA lowers the ELSD's operating temperature, eliminating semi-volatile sample loss to evaporation. This preserves sample integrity and maximizes response. This is demonstrated by

FIGS. 15 and 16

.

FIG. 15

is a chromatogram of the ELSD/LTA combination and

FIG. 16

is a chromatograph of the ELSD alone. Separation was by HPLC. Column was Alltima C18-LL, 5 μm, 250×2.1 mm. Mobile phase was a gradient of water: acetonitrile (Time (min.): % acetonitrile: 0:77, 10:80, 15:80, 20:95); flowrate 0.4 mL/min; sample size 20 μL loop. With respect to

FIG. 15

, drift tube and LTA temp. 30° C.; and nebulizing nitrogen flow 1.75 SLPM. With respect to

FIG. 16

, drift tube temp. 65° C., and nebulizing nitrogen flow 2.0 SLPM.




Example 4




The ELSD delivers a stable baseline and excellent sensitivity for a simple sugar separation. Because carbohydrates are non-volatile and the mobile phase is mostly organic, the ELSD alone is preferred.

FIG. 17

demonstrates this. The separation was by HPLC. Column was Absorbosphere, NH


2


250 mm×4.6 mm, sample size was 1 mg sugar standards/ml, mobile phase. Acetonitrile: water (85:15), flowrate 1.5 mL/min., drift tube temp. 90° C., nebulizing nitrogen flow 2.20 SLPM.




Example 5




The ELSD with the LTA detects corn syrup oligomers under gradient conditions. The ELSD/LTA combination is preferred for this application because of the high flowrate and highly aqueous mobile phase. The ELSD/LTA combination maintains a stable baseline during the gradient.




Example 6




Dimethicone analysis using the ELSD combined with non-aqueous reversed phase gradient elution achieves good resolution and detection sensitivity. Because dimethicone is a large non-volatile molecule and the mobile phase is 100% organic, the ELSD alone is preferred.




Example 7




The LTA maximizes sensitivity in the analysis of PEG


200


. The LTA reduces the ELSD's operating temperature and enhances the detection sensitivity of this small, semi-volatile compound. Thus,

FIG. 18

is a chromatogram demonstrating the preferred results with the ELSD/LTA combination. Separation by HPLC. Column was Econophere C8 5 micron 250×4.6 mm, mobile phase water: methanol gradient (Time (min): % methanol: 0:15, 25:40, 35:40), flowrate 1.0 mL/min., sample size 1 mg/mL, drift tube and LTA temp. 30° C., nebulizing nitrogen flow 1.75 SLPM, and sweep gas 2.5 SLPM.




Example 8




The ELSD alone is preferred for samples such as phospholipids. This configuration is ideal for normal phase applications.

FIG. 19

demonstrates this. The separation was by HPLC. Column was Allsphere Silica, 3 μm, 100×4.6 mm, mobile phase gradient of IPA: Hexane: Water (Time (min.): % IPA: % Hexane: % Water: 0:58:40:2; 7:52:40:8; 15:52: 40:8, flowrate 1.25 μL/min., column temp. ambient; drift tube temp. 65° C., nebulizing nitrogen flow 2.0 SLPM.




Example 9




The LTA enhances detector sensitivity in the analysis of underivatized low-chain fatty acids. The LTA substantially lowers the ELSD's operating temperature, preventing sample loss to evaporation. A chromatogram using the preferred combination of the ELSD/LTA is shown in FIG.


19


. The separation was by HPLC. Column was Alltima C18, LL, 5 mm (250×2.1 mm), sample size 20 μL injection loop, mobile phase, gradient water: acetonitrile (time (min.): % of acetonitrile): 0:77, 5:80, 10:80, 20:95; flowrate 0.4 ml/min., drift tube and LTA temp. 30° C., and nebulizing nitrogen flow 1.25 SLPM.




Example 10




Large macrolides are not subject to sample evaporation, therefore the ELSD alone is preferred.




Example 11




Assessing lead drug purity is preferred using the ELSD/LTA combination compared to UV because the ELSD's signal closely reflects the sample's mass balance. The LTA accepts high flowrates and operates at low temperatures for the extreme gradient conditions used during high-throughput screening. This is demonstrated by

FIGS. 23 and 24

.

FIG. 23

is a chromatogram from using UV detection.

FIG. 21

is a chromatogram generated by the preferred ELSD/LTA combination. The separation was by HPLC. Column was Alltima C18, 5 mm, 50×2.1 mm, mobile phase gradient of water (0.1% formic acid): acetonitrile (0.1% formic acid) (time (min): % acetonitrile): 0:5, 10:95, 11:95; flowrate 0.5 mL/min., column temp. 40° C. With respect to

FIG. 23

, detection by UV at 220 nm. With respect to

FIG. 24

, LTA drift tube and LTA temp. 30° C., and nebulizing nitrogen flow 1.75 SLPM.



Claims
  • 1. A method for quickly converting from a single-flow configuration to a split-flow configuration of evaporative light scattering detection thereby providing increased ability to detect different sample types in different mobile phases, the method comprising:providing an evaporative light scattering detection device in the single-flow configuration comprising a nebulizer in fluid communication with one end of a drift tube, a light source and a detector; and converting to a split-flow configuration by removing the nebulizer and connecting a low temperature adaptor such that the low temperature adaptor is in fluid communication with the drift tube, the low temperature adapter comprising a low temperature adapter nebulizer, a nebulization chamber in fluid communication with the low temperature adapter nebulizer and the drift tube, wherein in the nebulization chamber at least a portion of a mobile phase carrying sample components is evaporated and a portion of the mobile phase is not evaporated, the nebulization chamber further comprising a sink trap in fluid communication with the nebulization chamber for removing mobile phase that is not evaporated in the nebulization chamber.
  • 2. The system of claim 1 wherein the low temperature adapter has a sweep gas channel for introducing sweep gas into the nebulization chamber.
  • 3. The system of claim 1 wherein heat tape is affixed to the nebulization chamber of the low temperature adaptor at pre-determined intervals.
  • 4. The method of claim 1 wherein the nebulizer and the low temperature adapter nebulizer are the same.
  • 5. The system of claim 4 wherein heat tape is affixed to the coil of the low temperature adaptor at pre-determined intervals.
  • 6. The method of claim 1 wherein the nebulization chamber of the low temperature adapter is in fluid communication with the drift tube via a connection tube.
  • 7. The method of claim 6 wherein the connection tube and the nebulization chamber are in fluid communication via a coil.
  • 8. The method of claim 1 comprising the further step of converting back to the single-flow configuration by removing the low temperature adapter and attaching a nebulizer such that it is in fluid communication with the drift tube.
  • 9. The method of claim 8 wherein the nebulizer and the low temperature adapter nebulizer are the same.
US Referenced Citations (2)
Number Name Date Kind
4958529 Vestal Sep 1990 A
5807750 Baum et al. Sep 1998 A
Non-Patent Literature Citations (3)
Entry
“New! Alltech 500 ELSD—Your Best Choice For Solving Tough Detection Problems”—Bulletin ™338A, Alltech Associates, Inc., Deerfield, IL.
“Sedex 55: Evaporative Light Scattering Detector Instruction Manual”, Sedere, ANVAR-University of Orléans, France.
DDL 31 User's Instruction Manual: Version 2.0 (GB) Sep., 1996, EUROSEP Instruments, France.